Omniose
Business Services · Missouri, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
4340 Duncan Ave Ste 202, Saint Louis, Mi...Website
www.omniose.comRevenue
<$5 MillionIndustry
About Omniose
Omniose was founded in 2017 based on the pioneering glycoconjugation discoveries of the company's scientific founders Mario Feldman and Christian Harding through a scientific collaboration that characterized a new class of conjugating enzymes. The research operations were established at BioGenerator Accelerator Labs in St. Louis and the company was previously known as VaxNewMo. Omniose has been awarded grants from the US NIAID for use of the company's platform technology to develop vaccines against Group B Streptococcus, Klebsiella pneumoniae, and Streptococcus pneumoniae.Explore more
SIC Code 87,873NAICS Code 54,541Show moreOmniose Org Chart
Compare Similar Companies to Omniose
Compare insights from companies similar to Omniose, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Omniose Tech Stack
A closer look at the technologies used by Omniose
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Omniose
Sign Up For FreeTo access detailed company insights
Omniose was founded in 2017 based on the pioneering glycoconjugation discoveries of the company's scientific founders Mario Feldman and Christian Harding through a scientific collaboration that characterized a new class of conjugating enzymes. The research operations were established at BioGenerator Accelerator Labs in St. Louis and the company was... Read More